Erik Berg, Founder of AM Pharma

Erik Berg is the founder of AM Pharma. AM Pharma has raised $176M in total funding. Latest round: Series C. Backed by LSP, Andera Partners, Forbion.

About Erik Berg

Erik van den Berg is the CEO of AM-Pharma, a clinical stage biopharmaceutical company developing a treatment for acute kidney injury (AKI). Under his leadership, the company secured significant funding rounds to advance its recombinant human Alkaline Phosphatase (recAP) therapeutic through pivotal Phase III trials.

Erik Berg at a glance

More founders in Bunnik, The Netherlands (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library